I cant say I didn't try. We did a product with both market opportunity and one where the marginal cost would have allowed free distribution in needy countries. Inexpensive diagnostics help find conditions earlier so they can be treated more effectively and better human health, so very proud of what we achieved product-wise (whatever the business outcome.) Having a good country to work in with a sensible medical system and well-aligned incentives to improve the system allowed this. We tried to sell the idea/services in the US but the medical industry here is just out-of-control-complex-nonsensical.
That said, whatever one might think of the governments, we had a great time with the local population. We were a bit bubbled in a western "compound" and a US embassy school for the kids, but life was very easy there.
If you want apartment life, you can live/entertain pretty inexpensively on an artificial island with all things you might want: http://thepearlqatar.com/EN/TheIsland/Pages/The-Pearl-Qatar....
We did our best work in Qatar but there are early efforts in several other regional countries. The Arab embargos from this past summer really put a damper on that unfortunately. There is still hope, someone else is now running the effort and I hope it succeeds. Our top thing was real-time TB diagnosis for use at airports but we developed a number of other classifiers.
You are right, UAE is way ahead on the freezone aspect. Qatar, however, is way ahead on the academic front with the most concentrated selection of western academic branches (https://en.wikipedia.org/wiki/Education_City). For us, having a Cornell University Medical School branch next door, complete with tenured Cornell Med School professors was a huge sell for Qatar.